Nanozymes in Alzheimer's disease diagnostics and therapy-Reference-Cited by-同舟云学术

Nanozymes in Alzheimer's disease diagnostics and therapy

Published:2024 Issue:18 Volume:12 Page:4519-4545
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Li Linquan¹^ORCID,Zhang Wenyu¹,Cao Hengyi¹,Fang Leming¹,Wang Wenjing¹,Li Chengzhilin¹,He Qingbin¹,Jiao Jianwei¹²,Zheng Runxiao¹

Affiliation:

1. School of Clinical and Basic Medical Sciences, Medical Science and Technology Innovation Center, Shandong Provincial Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250000, China

2. State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

Abstract

The principle and application of nanozymes in the early diagnosis and treatment of Alzheimer's disease.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00586D

Reference200 articles.

1. Engineered urinary-derived extracellular vesicles loaded nanoenzymes as Trojan horses to regulate the inflammatory microenvironment for treatment of Alzheimer's disease

2. Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease

3. Recognition and Removal of Amyloid‐β by a Heteromultivalent Macrocyclic Coassembly: A Potential Strategy for the Treatment of Alzheimer's Disease

4. A Nanoformulation‐Mediated Multifunctional Stem Cell Therapy with Improved Beta‐Amyloid Clearance and Neural Regeneration for Alzheimer's Disease

5. Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice